E. Vinge et al., PHARMACOKINETICS OF CLOXACILLIN IN PATIENTS UNDERGOING HIP OR KNEE REPLACEMENT, European Journal of Clinical Pharmacology, 52(5), 1997, pp. 407-411
Objective: The pharmacokinetics of cloxacillin was investigated in 14
men and 24 women undergoing cemented hip (n = 19; age range 56-90) or
knee replacement surgery (n = 19; age range 51-84) for osteoarthritis.
Cloxacillin 1 g was given intravenously as a bolus dose at the induct
ion of anesthesia, and plasma samples and urine were collected for 6 h
. Drug levels were determined using HPLC. Results: Preoperative serum
creatinine levels were 84 mu mol.l(-1) in hip patients and 72 mu mol.l
(-1) in knee patients. The calculated values for creatinine clearance
were 63 and 85 ml.min(-1) 1.73 m(-2), respectively. Total clearance of
cloxacillin was 134 ml.min(-1).1.73 m(-2) in eighteen evaluated patie
nts undergoing hip replacement, and 162 ml.min(-1).1.73 m(-2) in eight
een patients undergoing knee surgery. Renal clearance was 72 and respe
ctively. Non-renal clearance was 57 ml.min(-1).1.73 m(-2) in hip patie
nts and 77 ml.min(-1).1.73 m(-2) in knee patients. Renal clearance of
cloxacillin correlated with the estimated creatinine clearance (r = 0.
652). Although women received higher doses than men (median 2.02 vs 2.
32 mmol.1.73 m(-2)), there were no sex differences in clearance correc
ted for body surface area. Conclusion: Total clearance of cloxacillin
was lower in patients undergoing hip replacement than in patients unde
rgoing replacement of the knee, but there was no difference between me
n and women.